Advertisement
Screener

LEMAITRE VASCULAR, INC. (LMAT) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

LEMAITRE VASCULAR, INC. Research and Development Expense

LEMAITRE VASCULAR, INC. (LMAT) reported Research and Development Expense of $4.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05

  • LEMAITRE VASCULAR, INC. research and development expense for the quarter ending 2026-06-30 was $4.85M, a 36.88% increase year-over-year.
  • LEMAITRE VASCULAR, INC. research and development expense for the quarter ending 2026-03-31 was $4.06M, a 0.85% decline year-over-year.
  • LEMAITRE VASCULAR, INC. research and development expense for the quarter ending 2025-12-31 was $3.53M, a 2.35% decline year-over-year.
  • LEMAITRE VASCULAR, INC. research and development expense for the quarter ending 2025-09-30 was $2.97M, a 18.76% decline year-over-year.
  • LEMAITRE VASCULAR, INC. research and development expense for fiscal 2025 was $14.14M, a 9.65% decline from fiscal 2024.
  • LEMAITRE VASCULAR, INC. research and development expense for fiscal 2024 was $15.65M, a 7.76% decline from fiscal 2023.
  • LEMAITRE VASCULAR, INC. research and development expense for fiscal 2023 was $16.97M, a 27.62% increase from fiscal 2022.
  • LEMAITRE VASCULAR, INC. research and development expense for fiscal 2022 was $13.29M, a 12.65% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-06-30$4.85M
10-Q · filed 2026-08-05
$8.91M
10-Q · filed 2026-08-05
$12.44M
derived: sum of 3 quarters · filed 2026-08-05
$15.41M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$4.06M
10-Q · filed 2026-05-06
$7.59M
derived: sum of 2 quarters · filed 2026-05-06
$10.56M
derived: sum of 3 quarters · filed 2026-05-06
$14.10M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$3.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.50M
derived: sum of 2 quarters · filed 2026-02-26
$10.04M
derived: sum of 3 quarters · filed 2026-08-05
$14.14M
10-K · filed 2026-02-26
2025-09-30$2.97M
10-Q · filed 2025-11-07
$6.51M
derived: sum of 2 quarters · filed 2026-08-05
$10.61M
10-Q · filed 2025-11-07
$14.22M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$3.54M
10-Q · filed 2026-08-05
$7.64M
10-Q · filed 2026-08-05
$11.25M
derived: sum of 3 quarters · filed 2026-08-05
$14.91M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$4.09M
10-Q · filed 2026-05-06
$7.71M
derived: sum of 2 quarters · filed 2026-05-06
$11.37M
derived: sum of 3 quarters · filed 2026-05-06
$15.65M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$3.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$7.27M
derived: sum of 2 quarters · filed 2026-02-26
$11.56M
derived: sum of 3 quarters · filed 2026-02-26
$15.65M
10-K · filed 2026-02-26
2024-09-30$3.66M
10-Q · filed 2025-11-07
$7.94M
derived: sum of 2 quarters · filed 2025-11-07
$12.03M
10-Q · filed 2025-11-07
$16.38M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$4.28M
10-Q · filed 2025-08-06
$8.38M
10-Q · filed 2025-08-06
$12.73M
derived: sum of 3 quarters · filed 2026-02-26
$16.95M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$4.09M
10-Q · filed 2025-05-08
$8.44M
derived: sum of 2 quarters · filed 2026-02-26
$12.67M
derived: sum of 3 quarters · filed 2026-02-26
$17.18M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$4.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.57M
derived: sum of 2 quarters · filed 2026-02-26
$13.09M
derived: sum of 3 quarters · filed 2026-02-26
$16.97M
10-K · filed 2026-02-26
2023-09-30$4.22M
10-Q · filed 2024-11-08
$8.74M
derived: sum of 2 quarters · filed 2024-11-08
$12.62M
10-Q · filed 2024-11-08
$16.17M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$4.52M
10-Q · filed 2024-08-08
$8.39M
10-Q · filed 2024-08-08
$11.95M
derived: sum of 3 quarters · filed 2025-02-28
$15.41M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$3.88M
10-Q · filed 2024-05-10
$7.43M
derived: sum of 2 quarters · filed 2025-02-28
$10.89M
derived: sum of 3 quarters · filed 2025-02-28
$14.24M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$3.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$7.02M
derived: sum of 2 quarters · filed 2025-02-28
$10.36M
derived: sum of 3 quarters · filed 2025-02-28
$13.29M
10-K · filed 2025-02-28
2022-09-30$3.46M
10-Q · filed 2023-11-07
$6.81M
derived: sum of 2 quarters · filed 2023-11-07
$9.74M
10-Q · filed 2023-11-07
$13.20M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$3.35M
10-Q · filed 2023-08-08
$6.28M
10-Q · filed 2023-08-08
$9.73M
derived: sum of 3 quarters · filed 2024-02-29
$12.58M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$2.93M
10-Q · filed 2023-05-09
$6.39M
derived: sum of 2 quarters · filed 2024-02-29
$9.24M
derived: sum of 3 quarters · filed 2024-02-29
$11.89M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$3.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$6.30M
derived: sum of 2 quarters · filed 2024-02-29
$8.96M
derived: sum of 3 quarters · filed 2024-02-29
$11.80M
10-K · filed 2024-02-29
2021-09-30$2.85M
10-Q · filed 2022-11-08
$5.50M
derived: sum of 2 quarters · filed 2022-11-08
$8.34M
10-Q · filed 2022-11-08
$11.21M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$2.65M
10-Q · filed 2022-08-05
$5.50M
10-Q · filed 2022-08-05
$8.37M
derived: sum of 3 quarters · filed 2023-03-01
$10.46M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$2.84M
10-Q · filed 2022-05-10
$5.71M
derived: sum of 2 quarters · filed 2023-03-01
$7.81M
derived: sum of 3 quarters · filed 2023-03-01
$9.95M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$2.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$4.97M
derived: sum of 2 quarters · filed 2023-03-01
$7.11M
derived: sum of 3 quarters · filed 2023-03-01
$10.10M
10-K · filed 2023-03-01
2020-09-30$2.10M
10-Q · filed 2021-11-04
$4.24M
derived: sum of 2 quarters · filed 2021-11-04
$7.23M
10-Q · filed 2021-11-04
$9.73M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$2.14M
10-Q · filed 2021-08-05
$5.13M
10-Q · filed 2021-08-05
$7.63M
derived: sum of 3 quarters · filed 2022-02-28
$9.91M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$2.99M
10-Q · filed 2021-05-10
$5.49M
derived: sum of 2 quarters · filed 2022-02-28
$7.77M
derived: sum of 3 quarters · filed 2022-02-28
$10.03M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$4.78M
derived: sum of 2 quarters · filed 2022-02-28
$7.04M
derived: sum of 3 quarters · filed 2022-02-28
$9.28M
10-K · filed 2022-02-28
2019-09-30$2.28M
10-Q · filed 2020-11-06
$4.54M
derived: sum of 2 quarters · filed 2020-11-06
$6.78M
10-Q · filed 2020-11-06
$9.12M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$2.26M
10-Q · filed 2020-08-06
$4.50M
10-Q · filed 2020-08-06
$6.84M
derived: sum of 3 quarters · filed 2021-03-12
$8.88M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$2.24M
10-Q · filed 2020-05-08
$4.59M
derived: sum of 2 quarters · filed 2021-03-12
$6.62M
derived: sum of 3 quarters · filed 2021-03-12
$8.61M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$4.38M
derived: sum of 2 quarters · filed 2021-03-12
$6.37M
derived: sum of 3 quarters · filed 2021-03-12
$8.20M
10-K · filed 2021-03-12
2018-09-30$2.04M
10-Q · filed 2019-11-08
$4.03M
derived: sum of 2 quarters · filed 2019-11-08
$5.85M
10-Q · filed 2019-11-08
$7.43M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$1.99M
10-Q · filed 2018-08-06
$3.81M
10-Q · filed 2019-08-06
$5.40M
derived: sum of 3 quarters · filed 2020-03-12
$7.16M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$1.82M
10-Q · filed 2019-05-06
$3.41M
derived: sum of 2 quarters · filed 2020-03-12
$5.17M
derived: sum of 3 quarters · filed 2020-03-12
$6.80M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$3.34M
derived: sum of 2 quarters · filed 2020-03-12
$4.98M
derived: sum of 3 quarters · filed 2020-03-12
$6.64M
10-K · filed 2020-03-12
2017-09-30$1.76M
10-Q · filed 2018-11-02
$3.40M
derived: sum of 2 quarters · filed 2018-11-02
$5.05M
10-Q · filed 2018-11-02
$6.58M
derived: sum of 4 quarters · filed 2019-03-11
2017-06-30$1.63M
10-Q · filed 2018-08-06
$3.29M
10-Q · filed 2018-08-06
$4.81M
derived: sum of 3 quarters · filed 2019-03-11
$6.35M
derived: sum of 4 quarters · filed 2019-03-11
2017-03-31$1.66M
10-Q · filed 2018-05-04
$3.18M
derived: sum of 2 quarters · filed 2019-03-11
$4.72M
derived: sum of 3 quarters · filed 2019-03-11
$6.35M
derived: sum of 4 quarters · filed 2019-03-11
2016-12-31$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
$3.06M
derived: sum of 2 quarters · filed 2019-03-11
$4.70M
derived: sum of 3 quarters · filed 2019-03-11
$6.14M
10-K · filed 2019-03-11
2016-09-30$1.54M
10-Q · filed 2017-11-03
$3.17M
derived: sum of 2 quarters · filed 2017-11-03
$4.62M
10-Q · filed 2017-11-03
$6.19M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$1.63M
10-Q · filed 2017-08-03
$3.08M
10-Q · filed 2017-08-03
$4.66M
derived: sum of 3 quarters · filed 2018-03-09
$6.08M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31$1.45M
10-Q · filed 2017-05-04
$3.02M
derived: sum of 2 quarters · filed 2018-03-09
$4.44M
derived: sum of 3 quarters · filed 2018-03-09
$5.77M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31$1.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$3.00M
derived: sum of 2 quarters · filed 2018-03-09
$4.33M
derived: sum of 3 quarters · filed 2018-03-09
$5.48M
10-K · filed 2018-03-09
2015-09-30$1.42M
10-Q · filed 2016-11-04
$2.75M
derived: sum of 2 quarters · filed 2016-11-04
$3.90M
10-Q · filed 2016-11-04
$4.99M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$1.33M
10-Q · filed 2016-08-05
$2.48M
10-Q · filed 2016-08-05
$3.56M
derived: sum of 3 quarters · filed 2017-03-09
$4.67M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$1.15M
10-Q · filed 2016-05-06
$2.23M
derived: sum of 2 quarters · filed 2017-03-09
$3.34M
derived: sum of 3 quarters · filed 2017-03-09
$4.48M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$2.19M
derived: sum of 2 quarters · filed 2017-03-09
$3.33M
derived: sum of 3 quarters · filed 2017-03-09
$4.67M
10-K · filed 2017-03-09
2014-09-30$1.11M
10-Q · filed 2015-11-06
$2.25M
derived: sum of 2 quarters · filed 2015-11-06
$3.59M
10-Q · filed 2015-11-06
$4.99M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$1.14M
10-Q · filed 2015-08-06
$2.48M
10-Q · filed 2015-08-06
$3.88M
derived: sum of 3 quarters · filed 2016-03-10
$5.18M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$1.34M
10-Q · filed 2015-05-07
$2.75M
derived: sum of 2 quarters · filed 2016-03-10
$4.05M
derived: sum of 3 quarters · filed 2016-03-10
$5.31M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$2.70M
derived: sum of 2 quarters · filed 2016-03-10
$3.97M
derived: sum of 3 quarters · filed 2016-03-10
$5.24M
10-K · filed 2016-03-10
2013-09-30$1.30M
10-Q · filed 2014-11-06
$2.57M
derived: sum of 2 quarters · filed 2014-11-06
$3.84M
10-Q · filed 2014-11-06
$5.40M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30$1.27M
10-Q · filed 2014-08-07
$2.54M
10-Q · filed 2014-08-07
$4.10M
derived: sum of 3 quarters · filed 2015-03-18
$5.36M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31$1.27M
10-Q · filed 2014-05-08
$2.83M
derived: sum of 2 quarters · filed 2015-03-18
$4.09M
derived: sum of 3 quarters · filed 2015-03-18
$5.23M
derived: sum of 4 quarters · filed 2015-03-18
2012-12-31$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
$2.82M
derived: sum of 2 quarters · filed 2015-03-18
$3.96M
derived: sum of 3 quarters · filed 2015-03-18
$5.09M
10-K · filed 2015-03-18
2012-09-30$1.26M
10-Q · filed 2013-11-07
$2.40M
derived: sum of 2 quarters · filed 2013-11-07
$3.53M
10-Q · filed 2013-11-07
$4.67M
derived: sum of 4 quarters · filed 2014-03-21
2012-06-30$1.14M
10-Q · filed 2013-08-09
$2.27M
10-Q · filed 2013-08-09
$3.41M
derived: sum of 3 quarters · filed 2014-03-21
$4.38M
derived: sum of 4 quarters · filed 2014-03-21
2012-03-31$1.14M
10-Q · filed 2013-05-08
$2.27M
derived: sum of 2 quarters · filed 2014-03-21
$3.25M
derived: sum of 3 quarters · filed 2014-03-21
$4.29M
derived: sum of 4 quarters · filed 2014-03-21
2011-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
$2.11M
derived: sum of 2 quarters · filed 2014-03-21
$3.15M
derived: sum of 3 quarters · filed 2014-03-21
$4.42M
10-K · filed 2014-03-21
2011-09-30$974.00K
10-Q · filed 2012-11-09
$2.01M
derived: sum of 2 quarters · filed 2012-11-09
$3.29M
10-Q · filed 2012-11-09
$4.76M
derived: sum of 4 quarters · filed 2013-03-27
2011-06-30$1.04M
10-Q · filed 2012-08-10
$2.31M
10-Q · filed 2012-08-10
$3.79M
derived: sum of 3 quarters · filed 2013-03-27
$4.92M
derived: sum of 4 quarters · filed 2013-03-27
2011-03-31$1.27M
10-Q · filed 2012-05-03
$2.75M
derived: sum of 2 quarters · filed 2013-03-27
$3.88M
derived: sum of 3 quarters · filed 2013-03-27
$5.22M
derived: sum of 4 quarters · filed 2013-03-27
2010-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27
$2.61M
derived: sum of 2 quarters · filed 2013-03-27
$3.95M
derived: sum of 3 quarters · filed 2013-03-27
$5.49M
10-K · filed 2013-03-27
2010-09-30$1.14M
10-Q · filed 2011-11-14
$2.47M
derived: sum of 2 quarters · filed 2011-11-14
$4.01M
10-Q · filed 2011-11-14
2010-06-30$1.34M
10-Q · filed 2011-08-12
$2.88M
10-Q · filed 2011-08-12
2009-12-31$5.91M
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77